Managing the availability of blood components for patients undergoing surgery under a cardiopulmonary bypass
Managing the availability of blood components in a multidisciplinary hospital providing surgical care is both determinant of quality treatment and safety risk. In this article the availability of blood components is considered within the context of high-tech medical care, including cardiopulmonary bypass surgery (CPB). The study was performed on the basis of Interregional Clinic and Diagnostic Center (hereinafter referred to as ICDC), which holds the predominant position in the Republic of Tatarstan in the area of high-tech medical care. ICDC is a top ten Russian medical centers by the number of medical cases. Currently, open-heart surgery under CPB is widespread. The prevention and treatment of hematologic disorders in correcting heart disease remains one of the contemporary challenges of trans-fusiology and cardiac surgery, despite the improvements in surgical techniques, the increasing development of perfusion science, and the growing possibilities of intensive care. A retrospective analysis of haemostasis in 160 patients operated under cardiopulmonary bypass in the cardiac surgery units of ICDC between 2017 and 2020 was carried out.